ArticlePharmaceutics2025

Development of Co-Amorphous Systems for Inhalation Therapy-Part 2: In Silico Guided Co-Amorphous Rifampicin-Moxifloxacin and -Ethambutol Formulations.

Eleonore Fröhlich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.